GE HealthCare Technologies (GEHC) Operating Income (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Operating Income came in at $739.0 million in Q2 2026, up 13.0% YoY from $654.0 million in Q2 2025, and up 43.5% on a QoQ basis from $515.0 million in Q1 2026.
GE HealthCare Technologies (GEHC) Operating Income (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Operating Income data on file, last reported at $739.0 million in Q2 2026.
- Quarterly Operating Income rose 13.0% year-over-year to $739.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.7 billion (down 0.94% YoY) and the FY2025 annual result came in at $2.8 billion, up 5.26% from the prior year.
- Operating Income grew to $739.0 million in Q2 2026, from $515.0 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $827.0 million in Q4 2025 to a low of $509.0 million in Q1 2022.
- A 5-year average of $644.4 million and a median of $630.0 million in 2022 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2025 — Operating Income increased 16.48% — and 2026, when it slipped 18.12%.
- Tracing GEHC's Operating Income over 5 years: stood at $777.0 million in 2022, then retreated by 11.33% to $689.0 million in 2023, then advanced by 16.26% to $801.0 million in 2024, then advanced by 3.25% to $827.0 million in 2025, then declined by 10.64% to $739.0 million in 2026.
- The last three Operating Income figures came in at $739.0 million (Q2 2026), $515.0 million (Q1 2026), and $827.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 129.82 Bn | 126.34 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 120.34 Bn | 111.12 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 74.41 Bn | 73.88 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.56 Bn | 48.31 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.76 Bn | 32.82 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 33.84 Bn | 31.73 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn | 326.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 739.00 Mn |
| Mar 31, 2026 | 515.00 Mn |
| Dec 31, 2025 | 827.00 Mn |
| Sep 30, 2025 | 653.00 Mn |
| Jun 30, 2025 | 654.00 Mn |
| Mar 31, 2025 | 629.00 Mn |
| Dec 31, 2024 | 801.00 Mn |
| Sep 30, 2024 | 676.00 Mn |
| Jun 30, 2024 | 608.00 Mn |
| Mar 31, 2024 | 540.00 Mn |
| Dec 31, 2023 | 689.00 Mn |
| Sep 30, 2023 | 617.00 Mn |
| Jun 30, 2023 | 570.00 Mn |
| Mar 31, 2023 | 559.00 Mn |
| Dec 31, 2022 | 777.00 Mn |
| Sep 30, 2022 | 605.00 Mn |
| Jun 30, 2022 | 631.00 Mn |
| Mar 31, 2022 | 509.00 Mn |